Search results
Results from the WOW.Com Content Network
Isoniazid has a boxed warning for severe and sometimes fatal hepatitis, which is age-dependent at a rate of 0.3% in people 21 to 35 years old and over 2% in those over age 50. [ 16 ] [ 28 ] Symptoms suggestive of liver toxicity include nausea, vomiting, abdominal pain, dark urine, right upper quadrant pain, and loss of appetite. [ 16 ]
The main result was a relative risk (RR) of 0.40 (95% confidence interval (CI) 0.31 to 0.52) for development of active tuberculosis over two years or longer for patients treated with INH, with no significant difference between treatment courses of six or 12 months (RR 0.44, 95% CI 0.27 to 0.73 for six months, and 0.38, 95% CI 0.28 to 0.50 for ...
Side effects are those of the underlying medications. [1] More common side effects include poor coordination, numbness, and liver problems. [2] Liver problems may be severe and are more likely in people over the age of 50. [2] Use is not recommended in children. [1] It is unclear if use in pregnancy is safe for the baby. [2]
Thinking about all this, I recently watched my friend Ginny Brooke take the stage with her guitar at an open mic night. This is a woman who rides her age like a trusty horse.
It is a fixed dose combination of rifampicin, isoniazid, and pyrazinamide. [1] It is used either by itself or along with other antituberculosis medication. [1] It is taken by mouth. [1] Side effects are those of the underlying medications. [1] These may include poor coordination, loss of appetite, nausea, joint pain, feeling tired, and numbness ...
Rifapentine, sold under the brand name Priftin, is an antibiotic used in the treatment of tuberculosis. [2] In active tuberculosis it is used together with other antituberculosis medications. [2] In latent tuberculosis it is typically used with isoniazid. [2] It is taken by mouth. [2]
For younger men, this type of cancer is the most deadly; for younger women, colorectal cancer comes in third behind breast and lung cancer, the National Cancer Institute states on its website.
Merck said its drug met the main goal of significantly reducing the time to disease worsening, lung transplantation or death in a late-stage study of 172 patients with advanced stages of the ...